BioCentury
ARTICLE | Company News

Sumitomo Dainippon Pharma Co. Ltd, DKSH deal

February 23, 2015 8:00 AM UTC

The companies added commercialization rights to a deal under which DKSH was responsible for obtaining regulatory approval for lurasidone in Thailand, Singapore and Hong Kong. Under the original deal, subsidiaries of DKSH submitted regulatory applications in Thailand and Hong Kong. A submission in Singapore is slated for this month. Sumitomo Dainippon said it will not receive an upfront payment under the expansion, and the companies declined to disclose further financial details. ...